Elia Marc — SEC insider filings
SEC reporting owner CIK 1830496. 15 insider filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2020-10-30 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 3,316,666 shares, $19,194,670 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 466,666 shares @ $15.00 ($6,999,990) in FRACTYL HEALTH, INC., filed 2024-02-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | Chief Executive Officer, Director | 7 | 3 legs · 2,850,000 sh · $12,194,680 | — | 6 |
| FRACTYL HEALTH, INC. (GUTS) | Director | 4 | 1 leg · 466,666 sh · $6,999,990 | — | 5 |
| SQZ Biotechnologies Co (SQZ) | Director | 4 | — | — | 4 |
Insider filings — Elia Marc
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Invivyd, Inc. (IVVD) | Grant/award (A): 10,700,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | FRACTYL HEALTH, INC. (GUTS) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Invivyd, Inc. (IVVD) jointly with M28 Capital Management LP | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | FRACTYL HEALTH, INC. (GUTS) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Invivyd, Inc. (IVVD) jointly with M28 Capital Management LP | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Invivyd, Inc. (IVVD) jointly with M28 Capital Management LP | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | Fractyl Health, Inc. (GUTS) jointly with M28 Capital Management LP | Conversion (C): 1,389,451 · Purchase (P): 466,666 @ $15 · Conversion (C): 2,981,763 (derivative) | EDGAR |
| 2024-02-05 | 4 | Fractyl Health, Inc. (GUTS) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | SQZ Biotechnologies Co (SQZ) | Grant/award (A): 39,875 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | Invivyd, Inc. (IVVD) jointly with M28 Capital Management LP | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-08-19 | 4 | Adagio Therapeutics, Inc. (ADGI) jointly with M28 Capital Management LP | Purchase (P): 1,000,000 @ $4.04 · Purchase (P): 1,265,549 @ $4.31 · Purchase (P): 584,451 @ $4.62 | EDGAR |
| 2022-06-24 | 4 | Adagio Therapeutics, Inc. (ADGI) jointly with M28 Capital Management LP | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | SQZ Biotechnologies Co (SQZ) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | SQZ Biotechnologies Co (SQZ) | Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2020-10-30 | 4 | SQZ Biotechnologies Co (SQZ) | Grant/award (A): 7,055 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830496 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs